EP0381216B1 — Hydrochlorofluorocarbon azeotropic or azeotropic-like mixture
Assigned to AGC Inc · Expires 1995-12-27 · 30y expired
What this patent protects
A hydrochlorofluorocarbon azeotropic or azeotropic-like mixture comprising at least one member selected from the group consisting of hydrogen-containing fluoropropanes of the formula I: CHaClbFcCF2CHxClyFz (I) wherein a+b+c=3, x+y+z=3, a+x>/=1, b+…
USPTO Abstract
A hydrochlorofluorocarbon azeotropic or azeotropic-like mixture comprising at least one member selected from the group consisting of hydrogen-containing fluoropropanes of the formula I: CHaClbFcCF2CHxClyFz (I) wherein a+b+c=3, x+y+z=3, a+x>/=1, b+y>/=1, and 0</=a,b,c,x,y,z</=3, and at least one member selected from the group of compounds II consisting of halogenated hydrocarbons having a boiling point of from 20 to 85 DEG C other than said hydrochlorofluoropropanes, hydrocarbons having a boiling point of from 20 to 85 DEG C and alcohols having from 1 to 4 carbon atoms.
Drugs covered by this patent
- Victrelis (BOCEPREVIR) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.